GILD Stock: Gilead Plots A Massive Move Into Oncology With A Third Of Sales By 2030 | Investor's Business Daily
![GILD Stock Dives As Profit Lags Forecasts Despite Strong Cancer Drug Sales | Investor's Business Daily GILD Stock Dives As Profit Lags Forecasts Despite Strong Cancer Drug Sales | Investor's Business Daily](https://www.investors.com/wp-content/uploads/2020/04/Stock-Gilead-07-adobe.jpg)
GILD Stock Dives As Profit Lags Forecasts Despite Strong Cancer Drug Sales | Investor's Business Daily
![Gilead Sciences Stock Forecast: up to 78.655 USD! - GILD Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Gilead Sciences Stock Forecast: up to 78.655 USD! - GILD Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/57/stock-gild-stock-forecast.png?v=1690831682)
Gilead Sciences Stock Forecast: up to 78.655 USD! - GILD Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
![Gilead Sciences Stock Forecast: up to 78.655 USD! - GILD Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis Gilead Sciences Stock Forecast: up to 78.655 USD! - GILD Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis](https://walletinvestorstorage.b-cdn.net/forecast-graphs/57/stock-gild-stock-forecast-components.png?v=1690831682)